Related Experiment Video

Updated: Jul 27, 2026

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover
08:03

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover

Published on: May 23, 2016

Significance of the DNA synthesis in hypertrophic cardiomyopathies

L Matturri1, B Biondo, B Colombo

  • 1Institute of Pathology, Milan, Italy.

Basic Research in Cardiology
|April 1, 1997
PubMed

Insights

In hypertrophic cardiomyopathy (HCM), increased DNA replication in heart cells suggests a repair process, not just cell division or death. This DNA renewal aims to fix damaged DNA molecules in HCM hearts.

Area of Science:

  • Cardiovascular Biology
  • Cellular and Molecular Medicine
  • Cardiac Pathophysiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is characterized by abnormal heart muscle growth.
  • Understanding the cell cycle dynamics and DNA content in HCM is crucial for elucidating disease mechanisms.
  • Previous studies suggest alterations in myocardial cell ploidy in cardiac hypertrophy.

Purpose of the Study:

  • To investigate DNA content and proliferating cell nuclear antigen (PCNA) expression in normal, hemodynamically overloaded hypertrophic, and HCM hearts.
  • To determine if hyperdiploid myocardial cells in these conditions are in a dynamic or static phase.
  • To elucidate the underlying processes of DNA changes in HCM.

Main Methods:

  • Comparative analysis of DNA content and PCNA expression in myocardial tissue from different heart conditions.
  • Quantification of hyperdiploid cells and PCNA-positive cells.
  • Statistical analysis to compare cell populations between groups.

Main Results:

  • A significantly higher percentage of PCNA-positive cells (25.4%) was observed exclusively in the HCM group compared to hyperdiploid cells (9.3%).
  • This indicates that DNA replication occurs via a distinct process in HCM, deviating from the normal cell cycle.
  • The findings suggest an increase in ploidy and potential for mitosis.

Conclusions:

  • The observed DNA replication in HCM is not solely due to normal cell cycle progression, increased apoptosis, or simple DNA renewal.
  • These findings strongly suggest a DNA repair mechanism in response to various molecular damages in HCM.
  • This repair process contributes to the altered DNA content and cellular dynamics in hypertrophic cardiomyopathy.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...